Poseida Therapeutics, Inc.

About Poseida Therapeutics, Inc.

Poseida Therapeutics is focused on developing innovative solutions to redefine treatment paradigms for life-threatening cancers and genetic diseases. Their genetic engineering technologies aim to advance cell and gene therapies, offering new hope to patients.

Products & Services

Genetic Engineering Platforms:Includes the non-viral piggyBac(r) DNA Delivery System for inserting large genetic payloads into the genome, and the Cas-CLOVER™ Site-Specific Gene Editing System for accurate site-specific edits in multiple cell types.

CAR-T Therapies:Developing fully allogeneic CAR-T therapies with an early memory phenotype to treat cancer patients.

Gene Therapies for Genetic Diseases:Targeting specific cell populations to develop functional cures for rare genetic diseases.

Specialties

Genetic Engineering Cell and Gene Therapies CAR-T Therapies Non-Viral DNA Delivery Site-Specific Gene Editing

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Strategic Investment T: - FT: Strategic Investment	A: 50000000 MR: - FA: $50 million FAN: 50000000	D: 2023-08-08 FD: 2023-08-08	1 investors
2	RT: Strategic Investment T: - FT: Strategic Investment	A: 50000000 MR: - FA: $50 million FAN: 50000000	D: 2023-08-07 FD: 2023-08-07	1 investors

Strategic Investment Latest

2023-08-08

$50.0M

1 investor (Pro only)

Strategic Investment 2023-08-07

$50.0M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

T

Thomas G. Martin

M.D.

Recent News